Predictive significance of preoperative CT findings for suboptimal cytoreduction in advanced ovarian cancer: a meta-analysis

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
   PubMed Web of Science ®Google Scholar
• VergoteITropéCGAmantFNeoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancerN Engl J Med20103631094395320818904
   PubMed Web of Science ®Google Scholar
• du BoisAReussAPujade-LauraineEHarterPRay-CoquardIPfistererJRole of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO)Cancer200911561234124419189349
   PubMed Web of Science ®Google Scholar
• ChiDSEisenhauerELLangJWhat is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?Gynecol Oncol2006103255956416714056
   PubMed Web of Science ®Google Scholar
• OzolsRFBundyBNGreerBEPhase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyJ Clin Oncol200321173194320012860964
   PubMed Web of Science ®Google Scholar
• ChiDSFranklinCCLevineDAImproved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approachGynecol Oncol200494365065415350354
   PubMed Web of Science ®Google Scholar
• HoskinsWJMcGuireWPBradyMFThe effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaAm J Obstet Gynecol19941704974979 discussion 979–9808166218
   PubMed Web of Science ®Google Scholar
• AxtellAELeeMHBristowREMulti-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancerJ Clin Oncol200725438438917264334
   PubMed Web of Science ®Google Scholar
• BorleyJWilhelm-BenartziCYazbekJRadiological predictors of cytoreductive outcomes in patients with advanced ovarian cancerBJOG2015122684384925132394
   PubMed Web of Science ®Google Scholar
• SonHMKimSHKwonBRKimMJKimCSChoSHPreoperative prediction of suboptimal resection in advanced ovarian cancer based on clinical and CT parametersActa Radiol201758449850427439399
   PubMed Web of Science ®Google Scholar
• QayyumACoakleyFVWestphalenACHricakHOkunoWTPowellBRole of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancerGynecol Oncol200596230130615661212
   PubMed Web of Science ®Google Scholar
• DowdySCMullanySABrandtKRHuppertBJClibyWAThe utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinomaCancer2004101234635215241833
   PubMed Web of Science ®Google Scholar
• JancoJMGlaserGKimBDevelopment of a prediction model for residual disease in newly diagnosed advanced ovarian cancerGynecol Oncol20151381707725913130
   PubMed Web of Science ®Google Scholar
• GeresteinCGEijkemansMJBakkerJNomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancerAnticancer Res201131114043404922110240
   PubMed Web of Science ®Google Scholar
• SuidanRSRamirezPTSarasohnDMA multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancerGynecol Oncol2014134345546125019568
   PubMed Web of Science ®Google Scholar
• EverettENHeuserCCPastoreLMPredictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancerAm J Obstet Gynecol20051932568574 discussion 574–57616098898
   PubMed Web of Science ®Google Scholar
• MacKintoshMLRahimRRajashankerBCT scan does not predict optimal debulking in stage III–IV epithelial ovarian cancer: a multicentre validation studyJ Obstet Gynaecol201434542442824725017
   PubMedGoogle Scholar
• BristowREDuskaLRLambrouNCA model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomographyCancer20008971532154011013368
   PubMed Web of Science ®Google Scholar
• NelsonBERosenfieldATSchwartzPEPreoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinomaJ Clin Oncol19931111661728418230
   PubMed Web of Science ®Google Scholar
• WhitingPFRutjesAWWestwoodMEQUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studiesAnn Intern Med2011155852953622007046
   PubMed Web of Science ®Google Scholar
• DeeksJJAltmanDGDiagnostic tests 4: likelihood ratiosBMJ2004329745816816915258077
   PubMed Web of Science ®Google Scholar
• DinnesJDeeksJKirbyJRoderickPA methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracyHealth Technol Assess20059121113
   Web of Science ®Google Scholar
• StuckAERubensteinLZWielandDBias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneityBMJ19983167129469470471
   PubMed Web of Science ®Google Scholar
• DeeksJJMacaskillPIrwigLThe performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJ Clin Epidemiol200558988289316085191
   PubMed Web of Science ®Google Scholar
• ThompsonSGSharpSJExplaining heterogeneity in meta-analysis: a comparison of methodsStat Med199918202693270810521860
   PubMed Web of Science ®Google Scholar
• RisumSHøgdallCLoftAPrediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography – a prospective studyGynecol Oncol2008108226527018055006
   PubMed Web of Science ®Google Scholar
• SalaniRAxtellAGerardiMHolschneiderCBristowRELimited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancerGynecol Oncol2008108227127518164380
   PubMed Web of Science ®Google Scholar
• KimHJChoiCHLeeYYSurgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findingsTaiwan J Obstet Gynecol201453334334725286788
   PubMed Web of Science ®Google Scholar
• AlettiGDGostoutBSPodratzKCClibyWAOvarian cancer surgical resectability: relative impact of disease, patient status, and surgeonGynecol Oncol20061001333716153692
   PubMed Web of Science ®Google Scholar
• KangSKimTJNamBHPreoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysisJ Surg Oncol20101011131720025071
   PubMed Web of Science ®Google Scholar
• NickAMColemanRLRamirezPTSoodAKA framework for a personalized surgical approach to ovarian cancerNat Rev Clin Oncol201512423924525707631
   PubMed Web of Science ®Google Scholar
• FagottiAFerrandinaGFanfaniFA laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot studyAnn Surg Oncol20061381156116116791447
   PubMed Web of Science ®Google Scholar
• SimonRAltmanDGStatistical aspects of prognostic factor studies in oncologyBrit J Cancer19946969799858198989
   PubMed Web of Science ®Google Scholar
• MannCJHClinical prediction models: a practical approach to development, validation and updatingJ Royal Stat Soc2009172661662
   Google Scholar
• LakhmanYAkinOSohnMJEarly postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgeryAJR Am J Roentgenol201219861453145922623562
   PubMed Web of Science ®Google Scholar